Document is current
Any future updates will be listed below
-
Authors
Gupta, Venkata https://orcid.org/0000-0002-5700-7946
Weinberger, Barry https://orcid.org/0000-0003-2424-2875
Galanti, Stephanie G. https://orcid.org/0009-0005-5771-4498
Patel, Jimikumar https://orcid.org/0009-0007-3193-6935
Kasniya, Gangajal https://orcid.org/0009-0004-0385-0737
Kurepa, Dalibor https://orcid.org/0000-0002-4887-0289
- License Information
-
More Information
Article History
Received: 11 June 2024
Revised: 19 October 2024
Accepted: 30 October 2024
First Online: 22 November 2024
Competing interests
: Dalibor Kurepa has been clinical consultant for Chiesi Farmaceutici S.p.A. since April 2024. This company produces surfactants, however Chiesi Farmaceutici S.p.A. had no role in the production of this manuscript and is unrelated to the present work.
: The study was approved by the Northwell Health IRB (Feinstein Institutes, ID-21-1127-CCMC) as a quality improvement project, therefore no patient informed consent was needed for data collection.
